Ncs Multistage Holdings ((NCSM)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NCS Multistage Holdings struck an upbeat tone on its latest earnings call, balancing solid execution with a cautious view of 2026. Management highlighted double-digit revenue growth, rising margins, robust cash generation, and a stronger balance sheet, while acknowledging Canadian softness, modest margin pressure, and macro risks that could weigh on the coming year.
Full-Year Revenue Growth Beats Expectations
NCS delivered fiscal 2025 revenue of $183.6 million, up 13% year over year and 10% excluding the ResMetrics acquisition. The top line exceeded the high end of guidance, signaling resilient demand for the company’s technologies despite a mixed activity backdrop across North America.
Adjusted EBITDA Expansion Supports Profit Story
Adjusted EBITDA rose 20% year over year to $26.7 million, with margins improving to 14.5% from 13.7% a year earlier. This expansion underscores better operating efficiency and mix, helping offset pressures from certain weaker regions and higher costs.
Strong Q4 Caps the Year
Fourth-quarter 2025 revenue climbed to $50.6 million, up 13% versus last year and 9% sequentially. Q4 adjusted EBITDA reached $9.2 million, with margins above 18% and again ahead of guidance, confirming solid momentum heading into 2026.
Cash Generation and Balance Sheet Strengthen
The company generated $22 million of free cash flow in 2025 and about $19 million after distributions, converting more than 70% of adjusted EBITDA into cash. NCS ended the year in a net cash position of roughly $29.1 million and total liquidity around $61 million, providing ample flexibility for investment.
ResMetrics Acquisition Delivers Early Benefits
NCS closed the ResMetrics acquisition on July 31, 2025, adding $5.2 million of revenue in just five months, including $2.9 million in Q4. Management has completed commercial integration in the U.S., upgraded lab IT systems, and plans to centralize U.S. lab and manufacturing in Tulsa while pursuing identified cost and revenue synergies.
Product Commercialization Drives Technology Adoption
The company highlighted multiple commercial wins, including the first Terrus AICV installation in Canada and growing adoption of StageSaver and Repeat Precision products. New offerings like the RapidTrace on-site tracer, Luminate samplers, SmartProp tracer, and the forthcoming Raytec Propex sliding sleeve for deepwater Gulf work are expanding NCS’s technology footprint.
Geographic Expansion Broadens Revenue Base
NCS grew revenue across the U.S., Canada, and international markets in 2025, underscoring a more diversified portfolio. The firm secured orders from two new customers in the Dutch North Sea and completed its first fracturing-systems well in the Middle East, supported by Repeat Precision sales in that region.
Profitability Lifted by Tax Recognition
Net income surged to $23.7 million, or $8.65 per share, up from $6.6 million a year ago, helped by the release of deferred tax valuation allowances worth $11.5 million. In Q4, net income was $15.0 million, or $5.34 per share, including a $9.8 million tax benefit, further boosting reported profitability.
Canada Weakness and Near-Term Headwinds
Despite overall growth, Canadian revenue fell 7% year over year in Q4, and management expects 2026 revenue from Canada to be lower amid reduced rig counts and customer consolidation. For Q1 2026, the company guided Canadian revenue to $26.5 million to $28.5 million, signaling a more cautious near-term outlook in that market.
Margins Face Modest Compression
Adjusted gross margin slipped to 42% in Q4 2025 from 43% a year earlier, with full-year margin around 41%, down roughly 40 basis points. For Q1 2026, management guided adjusted gross margin to 39%–41%, indicating a modest step down as pricing and mix pressures emerge.
Challenging Market and Seasonal Pattern
Management painted 2026 as a challenging year, with flat to lower activity expected in North America and more seasonal swings. Revenue and cash flow are forecast to be weighted toward the back half of the year, which could heighten timing risk for investors tracking quarterly performance.
Lower Free Cash Flow Guidance
After generating about $19 million of free cash flow after distributions in 2025, NCS now guides to $12 million to $16 million for 2026. While conversion from adjusted EBITDA remains strong, the mid-point implies a year-over-year decline in absolute free cash flow as growth moderates.
Non-Core Income and SG&A Variability
Other income declined to $4.8 million in 2025 from $7.3 million in 2024, reflecting royalty timing and the expiry of a technical service agreement that add variability to non-operating earnings. SG&A rose modestly to $58.8 million, driven by higher share-based compensation and ResMetrics costs, and management cautioned that cash-settled awards can make this line item somewhat volatile.
External Risks Not Embedded in Outlook
The company’s guidance intentionally excludes potential impacts from shifting trade or tariff policies between the U.S., Canada, and Mexico and does not factor in operational or pricing effects from the ongoing Middle East conflict. These external uncertainties present downside risk to the otherwise steady guidance framework.
Forward-Looking Guidance and Capital Plans
For Q1 2026, NCS expects revenue between $49 million and $53 million, adjusted EBITDA of $6.5 million to $8.5 million, and gross margins of 39%–41%. Full-year 2026 guidance calls for $184 million to $194 million in revenue, adjusted EBITDA of $26 million to $29 million, $1.5 million to $2.0 million in capital spending, and $12 million to $16 million in free cash flow after distributions, with cash generation skewed to the second half and medium-term targets reaffirmed.
NCS Multistage’s earnings call mixed strong 2025 execution with sober realism about a tougher 2026 backdrop. Investors are left with a company that beat its own targets, fortified its balance sheet, and expanded technologically and geographically, yet now faces softer Canada trends, slightly tighter margins, and macro risks that will test its ability to sustain recent momentum.